A vs B [Design Issues]

posted by mittyri  – Russia, 2020-02-03 22:05 (2336 d 16:42 ago) – Posting: # 21136
Views: 6,038

Hi John,

citing our Hero:

If one is really interested in λz and has no SD-phase in the study, sampling should continue until concentrations from previous doses are washed out – I would expect any estimate within the MD-profile to be biased towards faster elimination.

❝ I have seen both designs but I (and my former bosses) prefer method A. The only drawback I see from A is it takes longer time.


why does A take longer time?


Edit: Changed to internal link; see also this post #7[Helmut]

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
239 visitors (0 registered, 239 guests [including 15 identified bots]).
Forum time: 15:48 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5